Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.
|Articles|August 21, 2006
Medicare holds premiums steady for 2007
CMS announced that the average cost of Medicare prescription drug plans will remain at current levels or even drop in 2007. According to federal officials, the average premium will be $24 or possibly even less next year.
Advertisement
Medicare holds premiums steady for 2007
CMS announced that the average cost of Medicare prescription drug plans will remain at current levels or even drop in 2007. According to federal officials, the average premium will be $24 or possibly even less next year. CMS attributed the price freeze to competition among health plans, with the bidding among Medicare Advantage prescription drug plans especially keen. "The power of Medicare beneficiaries making informed choices has already reduced the cost of the drug benefit by 25% on average in 2006, and as a result of continuing strong competition, more savings are on the way," explained CMS administrator Mark McClellan, M.D., Ph.D.
To see more Hot off the Press news articles, click here
Advertisement
Related to this article
This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.
Cheri Schmit explains how pharmacists' roles are growing beyond dispensing into prevention, test-and-treat, and artificial intelligence-supported patient care.
In celebration of American Pharmacists Month, Melissa McGivney, PharmD, FAPhA, FCCP, provides a snapshot of where the profession has come and where it still has to go.
Pharmacist-backed picks help families manage fever and pain, seasonal allergies, and cough and congestion as kids head back to the classroom.
Sara Hover, RPh, FAARM, explains how these products are putting pharmacists at the center of safety and evidence evaluations one patient at a time.
Independent pharmacies adapt to specialty drugs, biosimilars, cold-chain, and REMS demands.
During American Pharmacists Month, pharmacy teams reflect on their roles and explore ways to enhance patient care.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Must Guide Peptide Talks Pending FDA Action | NCPA 2026
2
FDA Approves Brytly for OTC Eye Redness Relief
3
Q&A: Emerging Compounded Therapies Demand Pharmacist’s Clinical Judgment | NCPA 2026
4
FDA Approves New Drug for HSV Lesions in Adults
5